Abstract
Genetic mutations in ion channel genes that are associated with cardiac arrhythmias have been identified over the past several decades. However, little is known about the pathophysiological processes. An important limitation has been the difficulty of using human cardiomyocytes to study arrhythmias and identify drugs. To circumvent this issue, we have developed a method using human-induced pluripotent stem cells to generate cardiomyocytes from individuals with Timothy syndrome (TS), a genetic disorder characterized by QT prolongation, ventricular tachycardia, and autism. The TS ventricular-like cardiomyocytes exhibit deficits in contraction, electrical signaling, and calcium handling, as revealed by live cell imaging and electrophysiological studies. We tested candidate drugs in TS cardiomyocytes and found that roscovitine could successfully rescue these cellular phenotypes. The use of a human cellular model of cardiac arrhythmias provides a useful new platform not only to study disease mechanisms but also to develop new therapies to treat cardiac arrhythmias.
Similar content being viewed by others
References
Roden, D. M., & Viswanathan, P. C. (2005). Genetics of acquired long QT syndrome. The Journal of Clinical Investigation, 115(8), 2025–2032. PMCID: 1180553.
Splawski, I., Timothy, K. W., Sharpe, L. M., Decher, N., Kumar, P., Bloise, R., et al. (2004). Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell, 119(1), 19–31.
Thiel, W. H., Chen, B., Hund, T. J., Koval, O. M., Purohit, A., Song, L. S., et al. (2008). Proarrhythmic defects in Timothy syndrome require calmodulin kinase II. Circulation, 118(22), 2225–2234.
Cheng, E. P., Yuan, C., Navedo, M. F., Dixon, R. E., Nieves-Cintron, M., Scott, J. D., et al. (2011). Restoration of normal L-type Ca2+ channel function during Timothy syndrome by ablation of an anchoring protein. Circulation Research, 109(3), 255–261. PMCID: 3151468.
Bader, P. L., Faizi, M., Kim, L. H., Owen, S. F., Tadross, M. R., Alfa, R. W., et al. (2011). Mouse model of Timothy syndrome recapitulates triad of autistic traits. Proceedings of the National Academy of Sciences of the United States of America, 108(37), 15432–15437. PMCID: 3174658.
Venetucci, L., Denegri, M., Napolitano, C., & Priori, S. G. (2012). Inherited calcium channelopathies in the pathophysiology of arrhythmias. Nature Reviews Cardiology, 9(10), 561–575.
Flucher, B. E., & Franzini-Armstrong, C. (1996). Formation of junctions involved in excitation–contraction coupling in skeletal and cardiac muscle. Proceedings of the National Academy of Sciences of the United States of America, 93(15), 8101–8106. PMCID: 38882.
Seisenberger, C., Specht, V., Welling, A., Platzer, J., Pfeifer, A., Kuhbandner, S., et al. (2000). Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. Journal of Biological Chemistry, 275(50), 39193–39199.
Reichenbach, H., Meister, E. M., & Theile, H. (1992). The heart–hand syndrome. A new variant of disorders of heart conduction and syndactylia including osseous changes in hands and feet. Kinderärztliche Praxis, 60(2), 54–56.
Splawski, I., Timothy, K. W., Decher, N., Kumar, P., Sachse, F. B., Beggs, A. H., et al. (2005). Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proceedings of the National Academy of Sciences of the United States of America, 102(23), 8089–8096. discussion 6–8. PMCID: 1149428.
Gillis J, Burashnikov E, Antzelevitch C, Blaser S, Gross G, Turner L, et al. (2011) Long QT, syndactyly, joint contractures, stroke and novel CACNA1C mutation: expanding the spectrum of Timothy syndrome. Am J Med Genet A, doi:10.1002/ajmg.a.34355;PMCID:3319791
Barrett, C. F., & Tsien, R. W. (2008). The Timothy syndrome mutation differentially affects voltage- and calcium-dependent inactivation of CaV1.2 L-type calcium channels. Proceedings of the National Academy of Sciences of the United States of America, 105(6), 2157–2162. PMCID: 2538892.
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J., Hallmayer, J., & Dolmetsch, R. E. (2011). Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome. Nature, 471(7337), 230–234.
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., et al. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131(5), 861–872.
Takahashi, K., Okita, K., Nakagawa, M., & Yamanaka, S. (2007). Induction of pluripotent stem cells from fibroblast cultures. Nature Protocols, 2(12), 3081–3089.
Warren, L., Manos, P. D., Ahfeldt, T., Loh, Y. H., Li, H., Lau, F., et al. (2010). Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7(5), 618–630.
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., et al. (2011). A more efficient method to generate integration-free human iPS cells. Nature Methods, 8(5), 409–412.
Buganim, Y., Faddah, D. A., Cheng, A. W., Itskovich, E., Markoulaki, S., et al. (2012). Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell, 150(6), 1209–1222.
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., et al. (2008). Human cardiovascular progenitor cells develop from a KDR + embryonic-stem-cell-derived population. Nature, 453(7194), 524–528.
Laflamme, M. A., & Murry, C. E. (2011). Heart regeneration. Nature, 473(7347), 326–335.
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., et al. (2012). Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy. Science Translational Medicine, 4(130), 130ra47.
He, J. Q., Ma, Y., Lee, Y., Thomson, J. A., & Kamp, T. J. (2003). Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circulation Research, 93(1), 32–39.
Otsuji, T. G., Minami, I., Kurose, Y., Yamauchi, K., Tada, M., & Nakatsuji, N. (2010). Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs. Stem Cell Research, 4(3), 201–213.
Jung, C. B., Moretti, A., Mederos Schnitzle, Y. M., Lop, L., Storch, U., Bellin, M., et al. (2012). Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia. EMBO Molecular Medicine, 4(3), 180–191.
Grandi, E., Pasqualini, F. S., & Bers, D. M. (2010). A novel computational model of the human ventricular action potential and Ca transient. Journal of Molecular and Cellular Cardiology, 48(1), 112–121. PMCID: 2813400.
Pasca, S. P., Portmann, T., Voineagu, I., Yazawa, M., Shcheglovitov, A., Pasca, A. M., et al. (2011). Using iPSC-derived neurons to uncover cellular phenotypes associated with Timothy syndrome. Nature Medicine, 17(12), 1657–1662.
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., et al. (2011). Modelling the long QT syndrome with induced pluripotent stem cells. Nature, 471(7337), 225–229.
Yarotskyy, V., Gao, G., Du, L., Ganapathi, S. B., Peterson, B. Z., & Elmslie, K. S. (2010). Roscovitine binds to novel L-channel (CaV1.2) sites that separately affect activation and inactivation. Journal of Biological Chemistry, 285(1), 43–53. PMCID: 2804190.
Yarotskyy, V., Gao, G., Peterson, B. Z., & Elmslie, K. S. (2009). The Timothy syndrome mutation of cardiac CaV1.2 (L-type) channels: multiple altered gating mechanisms and pharmacological restoration of inactivation. The Journal of Physiology, 587(Pt 3), 551–565. PMCID: 2670080.
Cohen-Kutner, M., Yahalom, Y., Trus, M., & Atlas, D. (2012). Calcineurin controls voltage-dependent-inactivation (VDI) of the normal and Timothy cardiac channels. Scientific Reports, 2, 366.
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., et al. (2010). Patient-specific induced pluripotent stem-cell models for long-QT syndrome. The New England Journal of Medicine, 363(15), 1397–1409.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Yazawa, M., Dolmetsch, R.E. Modeling Timothy Syndrome with iPS Cells. J. of Cardiovasc. Trans. Res. 6, 1–9 (2013). https://doi.org/10.1007/s12265-012-9444-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-012-9444-x